site map

News Releases

2010
2009
2008
2007
2006
2005
2004

Nov 29 2004 Protox releases 3rd Quarter, 2004 financial statements
Oct 25, 2004 Agreement with Johns Hopkins University and the University of Victoria
Oct 7, 2004 Protox signs agreement with Waisman BioManufacturing Facility
Sep 21, 2004 Protox Expands Research Capacity
Sep 15, 2004 Protox grants stock options
Aug 17, 2004 Protox Retains Leading Research Organization
July 22, 2004 Protox appoints Director of Investor Relations
July 13, 2004 Protox Completes Qualifying Transaction and Raises $4.5 Million

2006 Protox Therapeutics Inc. All Rights Reserved. Legal Disclaimer.

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39